Journal article

The application of the CRISPR-Cas9 system in Pseudomonas syringae pv. Actinidiae

J Ho, M Zhao, S Wojcik, G Taiaroa, M Butler, R Poulter

Journal of Medical Microbiology | MICROBIOLOGY SOC | Published : 2020

Abstract

Introduction. Pseudomonas syringae pv. actinidiae (Psa) has emerged as a major bacterial pathogen of kiwifruit cultivation throughout the world. Aim. We aim to introduce a CRISPR-Cas9 system, a commonly used genome editing tool, into Psa. The protocols may also be useful in other Pseudomonas species. Methodology. Using standard molecular biology techniques, we modified plasmid pCas9, which carries the CRISPR-Cas9 sequences from Streptococcus pyogenes, for use in Psa. The final plasmid, pJH1, was produced in a series of steps and is maintained with selection in both Escherichia coli and Psa. Results. We have constructed plasmids carrying a CRISPR-Cas9 system based on that of S. pyogenes, whic..

View full abstract

University of Melbourne Researchers